Hot Penny Stocks to Buy Right Now? 7 For Your Watchlist
Making a penny stocks watchlist for July? Check these 7 out
The post Hot Penny Stocks to Buy Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
With July right around the corner, which penny stocks are investors adding to their watchlists? Right now, there is plenty for investors to consider when it comes to finding penny stocks to buy. This includes the pandemic coming to an end, fears of long-term inflation, and overall anxiety about the direction of the market. But, following an encouraging speech from Fed Chair, Jerome Powell, investors seem to be confident in the future of the stock market.
So in July, many are checking out biotech penny stocks, tech penny stocks, blockchain penny stocks, and a few others. These are just a couple of examples of popular industries to consider right now. With all of this in mind, let’s take a look at seven hot penny stocks to watch in July 2021.
Limelight Networks Inc. is a tech company working in the content delivery industry. This includes tools for clients that work to optimize digital delivery experiences. These clients work in industries such as live sporting events, movie launches, video games, apps, and more. Its team includes a variety of industry experts providing edge services swiftly and reliably. In its first-quarter 2021 financial report, the company posted some solid progress over the previous quarters.
CEO Bob Lyons stated that “as anticipated, our first quarter was challenging from a top and bottom-line perspective. That said, I am confident that we are now on the right path to achieve success. Our three-pillared strategy of improving the core, expand the core, and extend the core is serving as our playbook to transform the company and improve execution, profitability, and accelerate growth.”
Financially, the company pulled in revenue of around $51.2 million, while albeit being down by 10% over Q1 2020. Additionally, its non-GAAP net loss came in at $11 million or $0.09 per share. With all of this in mind, will LLNW be on your penny stocks watchlist?
2. Qudian Inc. (NYSE: QD)
Up by around 8% at midday are shares of Qudian Inc. To understand the company, let’s take a look at its recent Q1 2021 financial report, posted only a few days ago. Total revenue for the company fell by around 46% over the same period last year. However, it managed to increase its transaction service fee from a loss of around $20 million to a positive $7.7 million. Additionally, its sales income increased to $9.5 million, and interestingly enough, its operating costs decreased by a staggering 96%.
“In the first quarter of 2021, we continued to execute a prudent operational strategy related to our cash credit business amid an evolving regulatory environment while making significant strides to advance our early childhood business initiative. Our stringent credit risk control measures further improved our asset quality, evidenced by the continued decrease of the D1 delinquency rate for our loan book business.”
CEO and Founder, Mr. Min Luo
Qudian operates a tech platform that engages in the online consumer finance market in China. It offers lines of credit to millions of young individuals in China, that do not have access to standard credit lines. With the pandemic ending globally, Qudian could continue to see its numbers increase in the coming months. With this in mind, it could be worth considering for your list of penny stocks to watch.
3. Gran Tierra Energy Inc. (NYSE: GTE)
Another solid gainer of the day is Gran Tierra Energy Inc., pushing up by around 5% at midday. As its name implies, GTE is an energy company working in the oil and natural gas exploration industry. It finds and processes these resources in Colombia and Ecuador, and is actively pursuing other opportunities in the industry. After protests in Columbia a month or two ago, many investors thought production may slow at some of its facilities. However, the company stated that it should not be too large of an issue.
And, at the beginning of the month, Gran Tierra reported the results of its semi-annual credit facility redetermination and voting results from its annual stockholder meeting. While these updates may not seem like much, for investors, any update is one of consequence. And if we consider how fast penny stocks move, we see that large speculative jumps and declines are almost always caused by industry-specific or company-specific happenings.
Because of this, updates, no matter how big or small, are always worth paying attention to. Considering the growth of the oil industry and heightened demand as the pandemic ends, many believe that energy penny stocks could benefit in the coming months. Considering this, will GTE be on your penny stocks watchlist?
4. Meten Edtechx Education Group Ltd. (NASDAQ: METX)
Meten Edtechx Education Group is a company we’ve been covering for quite some time now. This penny stock is known as a leader in the ELT service providers market in China. It specializes in providing language lessons for English to both Chinese students and later life professionals. Because China engages in large international business operations, many students and professionals use English daily.
METX provides its services through an online digital platform. Because of this, its sophisticated system can reach students everywhere with the addition of a large nationwide network of learning centers. As a company, it offers its services through three leading brands known as Meten, ABC, and Likeshuo.
Meten targets adults and juniors seeking ELT services, while ABC is primarily purposed for juniors. Likeshuo is its online ELT program, offering remote teaching to students far from any learning center. The AI-centered platform is known for its novel technology and is one of the main reasons for the success of METX.
As the COVID-19 pandemic took hold of in-person teaching, companies such as METX were still able to perform. In fact, it recently announced that its student enrollment and subsequent gross billing increased by 247.8% in May of 2021. This has many investors excited and continues to be a major draw for the company. Considering this, METX could be worth keeping an eye on.
5. Predictive Oncology Inc. (NASDAQ: POAI)
Another penny stock worth checking out is Predictive Oncology. This company is run through three distinct segments Skyline, Helomics, and Soluble Biotech. Its four contained subsidiaries within these segments, Helomic’s Tumorgenesis, Skyline Medical, and Soluble Biotech, all work in the biomedical technology industry. This large conglomerate contains many facets to its business.
For example, Helomics, one of its building blocks, uses AI technology for optimizing personalized cancer therapies. By combining a rich data set that has been gathered from patient tumors, known targeted therapies can be implemented in treatment. This is a relatively new field in the fight against cancer and POAI is at the forefront of it. TumorGenesis also specializes in cancer therapy, providing researchers with better tools for advancing their studies in cancer.
Along with this, POAI also has its Skyline Medical division, which is a business that works in the measurement and disposal of waste fluid. This includes blood, irrigation fluid, and a variety of other substances. Medical disposal is an important component of the industry as a whole, yet it is easily overlooked. This is because the primary focus is on finding medical solutions rather than helping with day-to-day operations.
This is one of the reasons why many are looking towards POAI as a potential penny stock to watch. It has grown by around 40% in the past six months, coming back from an earlier slump in its prior years. Investors see this as an opportunity to find a penny stock at a low price, with the hopes of a potential future rally. Whether this makes POAI stock worth buying, however, is up to you.
6. GEE Group Inc. (NYSE: JOB)
The next penny stock on today’s list is a company that specializes in staffing solutions. The GEE Group has been in business since 1893 and is the provider of services to the employment market. JOB operates in two industry segments, and while related, have very distinct business models. Its staffing services provide professional solutions in the information technology, engineering, finance, and accounting specialties. The other segment is its commercial staffing service which operates through different SNI brand names.
With multiple specialties covered, JOB makes sure to find the right candidate for each position. This means that its broad range of experience in the staffing business makes it a leader in the sector as a whole. Trust and reliability go a long way in the business world and GEE has it all.
Currently, JOB is sitting at a low of around $0.55. This price was seen in June of last year and it grew to near $1.90 in the following months. Penny stocks go through fluctuations just as any stock does, however, they are typically more exaggerated. Looking at the price point now, it’s clear that JOB stock is highly volatile. With a reopening economy, JOB will be back in business. This will also be coupled with penny stocks investors who buy during consolidation and pullback periods such as the current one. How do you think JOB will do in the coming months?
7. Zomedica Corp. (NYSEAMERICAN: ZOM)
The last penny stock on today’s list is Zomedica Corp. This is a penny stock we have been talking about for weeks due to the high growth it has seen in the past YTD. With an increase of over 156%, ZOM saw a pullback recently which is a result of the natural ebb and flow of the market. ZOM holds a reported portfolio of $62 million in cash, which means it should have ample funding for the foreseeable future.
This company is also dependent on a reopening economy, which is predicted to come in the next few months. ZOM ‘s business is built immensely on in-person vet visits which have been sustainably lower than typical years because of the COVID-19 pandemic. Speculation of increased in-person business however has many investors buzzing about a potential stock price rebound. And, the number of domesticated animals owned in the U.S. has increased dramatically during the pandemic.
Truforma, one of its staple products, is a diagnostics platform that provides veterinarians with faster and more accurate data for generating a diagnostic profile. Specifically, Truforma is aimed at adrenal and thyroid disorders, common ailments of companion animals. Many growth investors are jumping on smaller cap stocks such as ZOM because of the high volatility and speculative potential growth. What do you think of ZOM as a penny stock? Will you be adding it to your watchlist these next coming months?
Which Penny Stocks Are You Watching?
By making a penny stocks watchlist, investors can effectively stay ahead of the game. And because penny stocks move so fast, being the first on the scene will always be a major benefit.
While it is difficult to accurately predict price action, having a trading education and access to real-time news will always put you ahead of the curve. Considering all of this, which penny stocks are you watching?
Former Project Veritas & O’Keefe Media Group operative and Pfizer formulation analyst scientist Justin Leslie revealed previously unpublished recordings showing Pfizer’s top vaccine researchers discussing major concerns surrounding COVID-19 vaccines. Leslie delivered these recordings to Veritas in late 2021, but they were never published:
Principal scientist at Pfizer, Kanwall Gill in 2021:
“We had no idea how it’s going to look like. MRNA vaccines have been there for 50 years, but nothing went to clinical trial because MRNA have been known to have side effects.”
Featured in Leslie’s footage is Kanwal Gill, a principal scientist at Pfizer. Gill was weary of MRNA technology given its long research history yet lack of approved commercial products. She called the vaccines “sneaky,” suggesting latent side effects could emerge in time.
Gill goes on to illustrate how the vaccine formulation process was dramatically rushed under the FDA’s Emergency Use Authorization and adds that profit incentives likely played a role:
Pfizer's principal scientist in 2021:
“It takes 10 year for a vaccine to come out. It takes years of observations... we are doing everything at the same time."
"It’s going to affect my heart, and I’m going to die. And nobody’s talking about that."
Leslie recorded another colleague, Pfizer’s pharmaceutical formulation scientist Ramin Darvari, who raised the since-validated concern that repeat booster intake could damage the cardiovascular system:
Pfizer's pharmaceutical formulation scientist, Ramin Darvari, in 2021:
“They’re engineering it specifically for me to take the next one, so increasing my consumption."
“It’s going to affect my heart, and I’m going to die. And nobody’s talking about that.”
None of these claims will be shocking to hear in 2024, but it is telling that high-level Pfizer researchers were discussing these topics in private while the company assured the public of “no serious safety concerns” upon the jab’s release:
Vaccine for Children is a Different Formulation
Leslie sent me a little-known FDA-Pfizer conference — a 7-hour Zoom meeting published in tandem with the approval of the vaccine for 5 – 11 year-olds — during which Pfizer’s vice presidents of vaccine research and development, Nicholas Warne and William Gruber, discussed a last-minute change to the vaccine’s “buffer” — from “PBS” to “Tris” — to improve its shelf life. For about 30 seconds of these 7 hours, Gruber acknowledged that the new formula was NOT the one used in clinical trials (emphasis mine):
“The studies were done using the same volume… but contained the PBS buffer. We obviously had extensive consultations with the FDA and it was determined that the clinical studies were not required because, again, the LNP and the MRNA are the same and the behavior — in terms of reactogenicity and efficacy — are expected to be the same.”
According to Leslie, the tweaked “buffer” dramatically changed the temperature needed for storage: “Before they changed this last step of the formulation, the formula was to be kept at -80 degrees Celsius. After they changed the last step, we kept them at 2 to 8 degrees celsius,” Leslie told me.
The claims are backed up in the referenced video presentation:
I’m no vaccinologist but an 80-degree temperature delta — and a 5x shelf-life in a warmer climate — seems like a significant change that might warrant clinical trials before commercial release.
Despite this information technically being public, there has been virtually no media scrutiny or even coverage — and in fact, most were told the vaccine for children was the same formula but just a smaller dose — which is perhaps due to a combination of the information being buried within a 7-hour jargon-filled presentation and our media being totally dysfunctional.
Bohemian Grove?
Leslie’s 2-hour long documentary on his experience at both Pfizer and O’Keefe’s companies concludes on an interesting note: James O’Keefe attended an outing at the Bohemian Grove.
Leslie offers this photo of James’ Bohemian Grove “GATE” slip as evidence, left on his work desk atop a copy of his book, “American Muckraker”:
My thoughts on the Bohemian Grove: my good friend’s dad was its general manager for several decades. From what I have gathered through that connection, the Bohemian Grove is not some version of the Illuminati, at least not in the institutional sense.
Do powerful elites hangout there? Absolutely. Do they discuss their plans for the world while hanging out there? I’m sure it has happened. Do they have a weird ritual with a giant owl? Yep, Alex Jones showed that to the world.
My perspective is based on conversations with my friend and my belief that his father is not lying to him. I could be wrong and am open to evidence — like if boxer Ryan Garcia decides to produce evidence regarding his rape claims — and I do find it a bit strange the club would invite O’Keefe who is notorious for covertly filming, but Occam’s razor would lead me to believe the club is — as it was under my friend’s dad — run by boomer conservatives the extent of whose politics include disliking wokeness, immigration, and Biden (common subjects of O’Keefe’s work).
Therefore, I don’t find O’Keefe’s visit to the club indicative that he is some sort of Operation Mockingbird asset as Leslie tries to depict (however Mockingbird is a 100% legitimate conspiracy). I have also met James several times and even came close to joining OMG. While I disagreed with James on the significance of many of his stories — finding some to be overhyped and showy — I never doubted his conviction in them.
As for why Leslie’s story was squashed… all my sources told me it was to avoid jail time for Veritas executives.
Feel free to watch Leslie’s full documentary here and decide for yourself.
Fun fact — Justin Leslie was also the operative behind this mega-viral Project Veritas story where Pfizer’s director of R&D claimed the company was privately mutating COVID-19 behind closed doors:
BREAKING: @Pfizer Exploring "Mutating" COVID-19 Virus For New Vaccines
"Don't tell anyone this...There is a risk...have to be very controlled to make sure this virus you mutate doesn't create something...the way that the virus started in Wuhan, to be honest."#DirectedEvolutionpic.twitter.com/xaRvlD5qTo
“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging biomarkers across the life course.”
Credit: 2024 Bozack et al.
“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging biomarkers across the life course.”
BUFFALO, NY- March 12, 2024 – A new research paper was published inAging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 4, entitled, “Associations of prenatal one-carbon metabolism nutrients and metals with epigenetic aging biomarkers at birth and in childhood in a US cohort.”
Epigenetic gestational age acceleration (EGAA) at birth and epigenetic age acceleration (EAA) in childhood may be biomarkers of the intrauterine environment. In this new study, researchers Anne K. Bozack, Sheryl L. Rifas-Shiman, Andrea A. Baccarelli, Robert O. Wright, Diane R. Gold, Emily Oken, Marie-France Hivert, and Andres Cardenas from Stanford University School of Medicine, Harvard Medical School, Harvard T.H. Chan School of Public Health, Columbia University, and Icahn School of Medicine at Mount Sinai investigated the extent to which first-trimester folate, B12, 5 essential and 7 non-essential metals in maternal circulation are associated with EGAA and EAA in early life.
“[…] we hypothesized that OCM [one-carbon metabolism] nutrients and essential metals would be positively associated with EGAA and non-essential metals would be negatively associated with EGAA. We also investigated nonlinear associations and associations with mixtures of micronutrients and metals.”
Bohlin EGAA and Horvath pan-tissue and skin and blood EAA were calculated using DNA methylation measured in cord blood (N=351) and mid-childhood blood (N=326; median age = 7.7 years) in the Project Viva pre-birth cohort. A one standard deviation increase in individual essential metals (copper, manganese, and zinc) was associated with 0.94-1.2 weeks lower Horvath EAA at birth, and patterns of exposures identified by exploratory factor analysis suggested that a common source of essential metals was associated with Horvath EAA. The researchers also observed evidence of nonlinear associations of zinc with Bohlin EGAA, magnesium and lead with Horvath EAA, and cesium with skin and blood EAA at birth. Overall, associations at birth did not persist in mid-childhood; however, arsenic was associated with greater EAA at birth and in childhood.
“Prenatal metals, including essential metals and arsenic, are associated with epigenetic aging in early life, which might be associated with future health.”
Read the full paper: DOI:https://doi.org/10.18632/aging.205602
Corresponding Author: Andres Cardenas
Corresponding Email:andres.cardenas@stanford.edu
Keywords: epigenetic age acceleration, metals, folate, B12, prenatal exposures
Click here to sign up for free Altmetric alerts about this article.
About Aging:
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.
Please visit our website at www.Aging-US.com and connect with us:
National insurance, income tax, VAT, capital gains tax, inheritance tax… it’s easy to get confused about the many different ways we contribute to the cost of running the country. The budget announcement is the key time each year when the government shares its financial plans with us all, and announces changes that may make a tangible difference to what you pay.
But you’ll likely be hearing a lot more about taxes in the coming months – promises to cut or raise them are an easy win (or lose) for politicians in an election year. We may even get at least one “mini-budget”.
If you’ve recently entered the workforce or the housing market, you may still be wrapping your mind around all of these terms. Here is what you need to know about the different types of taxes and how they affect you.
The UK broadly uses three ways to collect tax:
1. When you earn money
If you are an employee or own a business, taxes are deducted from your salary or profits you make. For most people, this happens in two ways: income tax, and national insurance contributions (or NICs).
If you are self-employed, you will have to pay your taxes via an annual tax return assessment. You might also have to pay taxes this way for interest you earn on savings, dividends (distribution of profits from a company or shares you own) received and most other forms of income not taxed before you get it.
VAT and excise duties are taxes on most goods and services you buy, with some exceptions like books and children’s clothing. About 20% of the total tax collected is VAT.
3. Taxes on wealth and assets
These are mainly taxes on the money you earn if you sell assets (like property or stocks) for more than you bought them for, or when you pass on assets in an inheritance. In the latter case in the UK, the recipient doesn’t pay this, it is the estate paying it out that must cover this if due. These taxes contribute only about 3% to the total tax collected.
You also likely have to pay council tax, which is set by the council you live in based on the value of your house or flat. It is paid by the user of the property, no matter if you own or rent. If you are a full-time student or on some apprenticeship schemes, you may get a deduction or not have to pay council tax at all.
This article is part of Quarter Life, a series about issues affecting those of us in our 20s and 30s. From the challenges of beginning a career and taking care of our mental health, to the excitement of starting a family, adopting a pet or just making friends as an adult. The articles in this series explore the questions and bring answers as we navigate this turbulent period of life.
Put together, these totalled almost £790 billion in 2022-23, which the government spends on public services such as the NHS, schools and social care. The government collects taxes from all sources and sets its spending plans accordingly, borrowing to make up any difference between the two.
Income tax
The amount of income tax you pay is determined by where your income sits in a series of “bands” set by the government. Almost everyone is entitled to a “personal allowance”, currently £12,570, which you can earn without needing to pay any income tax.
You then pay 20% in tax on each pound of income you earn (across all sources) from £12,570-£50,270. You pay 40% on each extra pound up to £125,140 and 45% over this. If you earn more than £100,000, the personal allowance (amount of untaxed income) starts to decrease.
If you are self-employed, the same rates apply to you. You just don’t have an employer to take this off your salary each month. Instead, you have to make sure you have enough money at the end of the year to pay this directly to the government.
The government can increase the threshold limits to adjust for inflation. This tries to ensure any wage rise you get in response to higher prices doesn’t lead to you having to pay a higher tax rate. However, the government announced in 2021 that they would freeze these thresholds until 2026 (extended now to 2028), arguing that it would help repay the costs of the pandemic.
Given wages are now rising for many to help with the cost of living crisis, this means many people will pay more income tax this coming year than they did before. This is sometimes referred to as “fiscal drag” – where lower earners are “dragged” into paying higher tax rates, or being taxed on more of their income.
National insurance
National insurance contributions (NICs) are a second “tax” you pay on your income – or to be precise, on your earned income (your salary). You don’t pay this on some forms of income, including savings or dividends, and you also don’t pay it once you reach state retirement age (currently 66).
While Jeremy Hunt, the current chancellor of the exchequer, didn’t adjust income tax meaningfully in this year’s budget, he did announce a cut to NICs. This was a surprise to many, as we had already seen rates fall from 12% to 10% on incomes higher than £242/week in January. It will now fall again to 8% from April.
While this is charged separately to income tax, in reality it all just goes into one pot with other taxes. Some, including the chancellor, say it is time to merge these two deductions and make this simpler for everyone. In his budget speech this year, Hunt said he’d like to see this tax go entirely. He thinks this isn’t fair on those who have to pay it, as it is only charged on some forms of income and on some workers.
I wouldn’t hold my breath for this to happen however, and even if it did, there are huge sums linked to NICs (nearly £180bn last year) so it would almost certainly have to be collected from elsewhere (such as via an increase in income taxes, or a lot more borrowing) to make sure the government could still balance its books.
There are likely to be further tweaks to the UK’s tax system soon, perhaps by the current government before the election – and almost certainly if there is a change of government.
Wealth taxes may be in line for a change. In the budget, the chancellor reduced capital gains taxes on sales of assets such as second properties (from 28% to 24%). These types of taxes provide only a limited amount of money to the government, as quite high thresholds apply for inheritance tax (up to £1 million if you are passing on a family home).
There are calls from many quarters though to look again at these types of taxes. Wealth inequality (the differences between total wealth held by the richest compared to the poorest) in the UK is very high (much higher than income inequality) and rising.
But how to do this effectively is a matter of much debate. A recent study suggested a one-off tax on total wealth held over a certain threshold might work. But wealth taxes are challenging to make work in practice, and both main political parties have already said this isn’t an option they are considering currently.
Andy Lymer and his colleagues at the Centre for Personal Financial Wellbeing at Aston University currently or have recently received funding for their research work from a variety of funding bodies including the UK's Money and Pension Service, the Aviva Foundation, Fair4All Finance, NEST Insight, the Gambling Commission, Vivid Housing and the ESRC, amongst others.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
